Anti-angiogenic therapy for uveal melanoma--more haste, less speed

Editorial

A W Stitt et al. Br J Ophthalmol. 2002 Apr.

. 2002 Apr;86(4):368-9.

doi: 10.1136/bjo.86.4.368.

No abstract available

Comment on

Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth.
Boyd SR, Tan DS, de Souza L, Neale MH, Myatt NE, Alexander RA, Robb M, Hungerford JL, Cree IA. Boyd SR, et al. Br J Ophthalmol. 2002 Apr;86(4):440-7. doi: 10.1136/bjo.86.4.440. Br J Ophthalmol. 2002. PMID: 11914215 Free PMC article.
Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: identification of a potential therapeutic window.
Boyd SR, Tan D, Bunce C, Gittos A, Neale MH, Hungerford JL, Charnock-Jones S, Cree IA. Boyd SR, et al. Br J Ophthalmol. 2002 Apr;86(4):448-52. doi: 10.1136/bjo.86.4.448. Br J Ophthalmol. 2002. PMID: 11914216 Free PMC article.

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182–6. - PubMed
1. Warren BA, Shubik P. The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest 1966;15:464–78. - PubMed
1. Cooke R. Dr Folkman's war: angiogenesis and the struggle to defeat cancer. New York: Random House, 2001.
1. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995;1:1024–8. - PubMed
1. Benjamin LE, Golijanin D, Itin A, et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 1999;103:159–65. - PMC - PubMed